Meridian Bioscience reported $33.99M in Gross Profit on Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbott ABT:US USD 5.78B 543M
Atrion ATRI:US USD 20.83M 3.46M
Becton, Dickinson and BDX:US USD 2.08B 9M
Bio Rad Laboratories BIO:US USD 375.09M 20.89M
Meridian Bioscience VIVO:US USD 33.99M 2.74M
Myriad Genetics MYGN:US USD 106M 23.6M
Orasure Technologies OSUR:US USD 46.19M 18.61M
Thermo Fisher Scientific TMO:US USD 4.43B 168M